多巴胺载体是缺血性中风的新目标
Yan-Qiong Cheng1, Ruo-Xi Zhang1, Xing-Yuan Li1
1Department of Pharmacy Research, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
CNS neuroscience & therapeutics
|October 29, 2024
概括
抑制多巴胺转运体 (DAT) 可能通过恢复突触功能和防止神经元死亡来预防缺血性中风. 多巴胺及其D1受体在这种神经保护作用中起着关键作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多巴胺转运体 (DAT) 调节多巴胺稳态,并与神经系统疾病有关.
- 它在预防缺血性中风方面的作用仍然在很大程度上未知.
研究的目的:
- 为了调查DAT在缺血性中风中的参与.
- 探索DAT抑制作为治疗策略的潜力.
主要方法:
- 在体内微透析以测量缺血小鼠大脑中的多巴胺水平.
- 利用Slc6a3 (DAT基因) 突变和过度表达的小鼠模型,这些小鼠模型遭受中脑动脉封闭 (MCAO).
- 服用了莱沃多巴 (Madopar) 和诺米芬辛,并评估了突触功能 (mEPSCs,mIPSCs) 和神经元存活率.
主要成果:
- MCAO增加了多巴胺水平;Slc6a3突变减少了损伤,而DAT过度表达使损伤恶化.
- 诺米芬辛和马多帕尔显示出神经保护作用.
- Slc6a3突变和多巴胺恢复了突触功能和神经元存活率,D1受体对手SCH-23390阻断了这些效应.
结论:
- DAT抑制是预防缺血性中风的潜在策略.
- 多巴胺及其D1受体对于恢复突触功能和在中风期间保护神经元至关重要.
更多相关视频
05:40AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
Published on: November 29, 2024
405
11:32Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
686
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake
961
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
961
